Fundz
Real-time · AI · Cross-signal

Noxopharm just moved. Here's exactly what to do next.

Who to reach, what to say, and why now — on Noxopharm, plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your planRequest a demo
▶
Watch the 2-minute tour · with sound

Noxopharm Partners with CRO for HERACLES Trial

Dec 04, 2024•over 1 year ago

Contract Type

partnership

BiotechnologyPharmaceutical

Description

Noxopharm has entered a partnership with a CRO for the HERACLES Trial, aiming to develop new cancer treatments.

Company Information

Company

Noxopharm

About

Noxopharm is a pharmaceutical company specializing in the development of cancer drugs.

Predictive Intelligence
Strategic

ML-powered predictions for Noxopharm's next move

Learn about Strategic plan

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months